|
Market Closed -
Other stock markets
|
After hours 14:59:58 | |||
| 10.68 EUR | -1.84% |
|
10.68 | 0.00% |
| 05-12 | Almirall: shares jump after a successful start to the year | CF |
| 05-12 | Almirall, S.A. Confirms Earnings Guidance for the Year 2025 | CI |
| Capitalization | 2.29B 2.64B 2.16B 1.96B 3.63B 229B 4.09B 25.59B 9.79B 105B 9.92B 9.71B 386B | P/E ratio 2025 * |
46x | P/E ratio 2026 * | 25.3x |
|---|---|---|---|---|---|
| Enterprise value | 2.25B 2.59B 2.12B 1.92B 3.56B 225B 4.01B 25.09B 9.6B 103B 9.73B 9.52B 378B | EV / Sales 2025 * |
2.04x | EV / Sales 2026 * | 1.74x |
| Free-Float |
35.93% | Yield 2025 * |
1.95% | Yield 2026 * | 1.68% |
More valuation ratios
* Estimated data
More news
Last Transcript: Almirall, S.A.
More press releases
More news
| 1 day | -1.84% | ||
| 1 week | -2.55% | ||
| Current month | -4.30% | ||
| 1 month | +4.71% | ||
| 3 months | +3.89% | ||
| 6 months | +30.80% | ||
| Current year | +29.69% |
| 1 week | 10.68 |  | 11.14 |
| 1 month | 10.2 | | 11.4 |
| Current year | 8.06 | | 11.4 |
| 1 year | 8.03 | | 11.4 |
| 3 years | 7.16 | | 11.4 |
| 5 years | 7.16 | | 15.35 |
| 10 years | 7.16 | | 19.36 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2022-11-01 | |
| Chief Executive Officer | 55 | - | |
Karl Ziegelbauer
CTO | Chief Tech/Sci/R&D Officer | - | 2021-07-06 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 64 | 2012-12-31 | |
| Director/Board Member | - | 2013-12-31 | |
Seth J. Orlow
BRD | Director/Board Member | - | 2015-12-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.84% | -2.55% | +8.59% | +7.23% | 2.68B | ||
| -2.68% | -6.63% | -13.66% | +157.28% | 705B | ||
| -1.03% | -4.97% | +1.02% | -13.71% | 363B | ||
| -2.58% | -7.83% | -52.12% | +25.00% | 333B | ||
| -0.27% | -3.30% | +7.34% | +28.79% | 328B | ||
| -0.27% | -3.86% | +3.72% | -14.84% | 255B | ||
| -0.34% | -2.34% | +0.59% | +19.15% | 228B | ||
| -1.52% | -5.41% | -16.18% | +3.36% | 220B | ||
| +0.36% | -2.85% | -38.78% | -9.83% | 199B | ||
| +0.33% | -1.66% | -6.32% | +21.77% | 156B | ||
| Average | -0.94% | -3.12% | -10.58% | +22.42% | 278.77B | |
| Weighted average by Cap. | -1.26% | -3.34% | -12.69% | +45.34% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.1B 1.27B 1.04B 945M 1.75B 110B 1.97B 12.32B 4.71B 50.52B 4.78B 4.68B 186B | 1.23B 1.42B 1.16B 1.06B 1.95B 123B 2.2B 13.77B 5.27B 56.48B 5.34B 5.23B 208B |
| Net income | 49.34M 56.89M 46.48M 42.23M 78.13M 4.93B 88.03M 550M 211M 2.26B 213M 209M 8.3B | 91.74M 106M 86.42M 78.52M 145M 9.16B 164M 1.02B 392M 4.2B 397M 388M 15.43B |
| Net Debt | -44.8M -51.65M -42.2M -38.34M -70.94M -4.47B -79.93M -500M -191M -2.05B -194M -190M -7.53B | -145M -167M -136M -124M -229M -14.47B -258M -1.62B -618M -6.63B -627M -613M -24.36B |
More financial data
* Estimated data
Employees
2,026
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-06-20 | 10.68 € | -1.84% | 481,206 |
| 25-06-19 | 10.88 € | +0.74% | 116,322 |
| 25-06-18 | 10.80 € | -0.92% | 99,198 |
| 25-06-17 | 10.90 € | -0.37% | 74,618 |
| 25-06-16 | 10.94 € | -0.18% | 119,707 |
Delayed Quote BME, June 20, 2025 at 11:35 am
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
10.88EUR
Average target price
11.91EUR
Spread / Average Target
+9.48%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ALM Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition